MX366204B - Pronostico medico y prediccion de la respuesta al tratamiento utilizando multiples actividades de la trayectoria de señalizacion celular. - Google Patents
Pronostico medico y prediccion de la respuesta al tratamiento utilizando multiples actividades de la trayectoria de señalizacion celular.Info
- Publication number
- MX366204B MX366204B MX2015014847A MX2015014847A MX366204B MX 366204 B MX366204 B MX 366204B MX 2015014847 A MX2015014847 A MX 2015014847A MX 2015014847 A MX2015014847 A MX 2015014847A MX 366204 B MX366204 B MX 366204B
- Authority
- MX
- Mexico
- Prior art keywords
- pathway
- wnt
- prediction
- signalling pathway
- treatment response
- Prior art date
Links
- 230000037361 pathway Effects 0.000 title abstract 10
- 230000005754 cellular signaling Effects 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 3
- 238000004393 prognosis Methods 0.000 title 1
- 230000004044 response Effects 0.000 title 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/20—Probabilistic models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Probability & Statistics with Applications (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
Abstract
La presente invención se refiere a un método para determinar una puntuación del riesgo que indica un riesgo de que un evento clínico ocurrirá dentro de un cierto período de tiempo. La puntuación del riesgo se basa al menos en parte en una combinación de actividades inferidas de dos o más trayectorias de señalización celular en un tejido y/o células y/o fluido corporal de un sujeto. Las trayectorias de señalización celular comprenden una trayectoria Wnt, una trayectoria ER, una trayectoria HH, y/o una trayectoria AR. La puntuación del riesgo se define de tal forma que el riesgo indicado de que ocurrirá un evento clínico dentro de un cierto período de tiempo se reduce con un PER en aumento y aumenta con un max (Pwnt, PHH) en aumento, en donde PER, Pwnt, y PHH denotan la actividad inferida de la trayectoria ER, la trayectoria Wnt, y la trayectoria HH, respectivamente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13165471 | 2013-04-26 | ||
| PCT/EP2014/058326 WO2014174003A1 (en) | 2013-04-26 | 2014-04-24 | Medical prognosis and prediction of treatment response using multiple cellular signalling pathway activities |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015014847A MX2015014847A (es) | 2016-03-11 |
| MX366204B true MX366204B (es) | 2019-07-02 |
Family
ID=48182831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015014847A MX366204B (es) | 2013-04-26 | 2014-04-24 | Pronostico medico y prediccion de la respuesta al tratamiento utilizando multiples actividades de la trayectoria de señalizacion celular. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11309059B2 (es) |
| EP (2) | EP3372695B1 (es) |
| JP (1) | JP6603208B2 (es) |
| KR (1) | KR102256141B1 (es) |
| CN (1) | CN105121665B (es) |
| AU (1) | AU2014259459B2 (es) |
| BR (1) | BR112015026736A2 (es) |
| CA (1) | CA2909991A1 (es) |
| MX (1) | MX366204B (es) |
| RU (1) | RU2718647C2 (es) |
| WO (1) | WO2014174003A1 (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014174003A1 (en) | 2013-04-26 | 2014-10-30 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signalling pathway activities |
| AU2014375206B2 (en) | 2014-01-03 | 2021-09-30 | Innosign B.V. | Assessment of the PI3K cellular signaling pathway activity using mathematical modelling of target gene expression. |
| US10016159B2 (en) | 2014-10-24 | 2018-07-10 | Koninklijke Philips N.V. | Determination of TGF-β pathway activity using unique combination of target genes |
| JP7065610B6 (ja) | 2014-10-24 | 2022-06-06 | コーニンクレッカ フィリップス エヌ ヴェ | 複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測 |
| AU2015334841B2 (en) | 2014-10-24 | 2022-02-03 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities |
| US11450409B2 (en) | 2015-08-14 | 2022-09-20 | Innosign B.V. | Determination of NFkB pathway activity using unique combination of target genes |
| CN109313196A (zh) * | 2016-06-13 | 2019-02-05 | 皇家飞利浦有限公司 | 用于推断对象中的信号转导途径的转录因子的活性的方法 |
| US20190385697A1 (en) * | 2017-02-14 | 2019-12-19 | The Regents Of The University Of Colorado, A Body Corporate | Methods for predicting transcription factor activity |
| EP3431582A1 (en) | 2017-07-18 | 2019-01-23 | Koninklijke Philips N.V. | Cell culturing materials |
| EP3461916A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat3 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3692170B1 (en) | 2017-10-02 | 2025-12-31 | Koninklijke Philips N.V. | DETERMINATION OF THE FUNCTIONAL STATE OF IMMUNE CELL TYPES AND OF AN IMMUNE RESPONSE |
| EP3461915A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3502279A1 (en) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3857564A1 (en) * | 2018-09-29 | 2021-08-04 | F. Hoffmann-La Roche AG | Multimodal machine learning based clinical predictor |
| JP7386897B2 (ja) * | 2019-05-03 | 2023-11-27 | コーニンクレッカ フィリップス エヌ ヴェ | 高悪性度漿液性卵巣癌における予後予測の方法 |
| EP3739588A1 (en) | 2019-05-13 | 2020-11-18 | Koninklijke Philips N.V. | Assessment of multiple signaling pathway activity score in airway epithelial cells to predict airway epithelial abnormality and airway cancer risk |
| WO2021022365A1 (en) * | 2019-08-02 | 2021-02-11 | Intellijoint Surgical Inc. | Systems and methods to collaborate, to train an expert system and to provide an expert system |
| EP3882363A1 (en) | 2020-03-17 | 2021-09-22 | Koninklijke Philips N.V. | Prognostic pathways for high risk sepsis patients |
| KR102565378B1 (ko) * | 2020-03-23 | 2023-08-10 | 단국대학교 산학협력단 | 유방암 호르몬 수용체의 상태 예측을 위한 바이오 마커 |
| EP3978628A1 (en) | 2020-10-01 | 2022-04-06 | Koninklijke Philips N.V. | Prognostic pathways for viral infections |
| WO2021209567A1 (en) | 2020-04-16 | 2021-10-21 | Koninklijke Philips N.V. | Prognostic pathways for viral infections |
| EP3940704A1 (en) | 2020-07-14 | 2022-01-19 | Koninklijke Philips N.V. | Method for determining the differentiation state of a stem cell |
| EP3960875A1 (en) * | 2020-08-28 | 2022-03-02 | Koninklijke Philips N.V. | Pcr method and kit for determining pathway activity |
| EP3965119A1 (en) | 2020-09-04 | 2022-03-09 | Koninklijke Philips N.V. | Methods for estimating heterogeneity of a tumour based on values for two or more genome mutation and/or gene expression related parameter, as well as corresponding devices |
| EP3974540A1 (en) | 2020-09-25 | 2022-03-30 | Koninklijke Philips N.V. | Method for predicting immunotherapy resistance |
| KR102189142B1 (ko) * | 2020-10-15 | 2020-12-09 | 서울대학교병원 | 만성신장질환의 악화 예측 마커로서의 snp 및 이의 이용 |
| EP4015651A1 (en) | 2020-12-17 | 2022-06-22 | Koninklijke Philips N.V. | Treatment prediction and effectiveness of anti-tnf alpha treatment in ibd patients |
| EP4039825A1 (en) | 2021-02-09 | 2022-08-10 | Koninklijke Philips N.V. | Comparison and standardization of cell and tissue culture |
| US20250262192A1 (en) | 2021-03-11 | 2025-08-21 | Koninklijke Philips N.V. | Prognostic pathways for high risk sepsis patients |
| CN114410667B (zh) * | 2021-12-31 | 2022-10-11 | 广东省科学院动物研究所 | 一种鞍带石斑鱼znrf3基因及其编码的蛋白和应用 |
| KR102508252B1 (ko) * | 2022-01-11 | 2023-03-09 | 주식회사 볼츠만바이오 | 생체신호전달 네트워크 모델의 학습방법 및 이를 위한 장치 |
| CN114524872A (zh) * | 2022-03-09 | 2022-05-24 | 广州诺诚生物技术研发有限公司 | 一种用于乳腺癌检测的单克隆抗体及其试剂盒 |
| CN120138048A (zh) * | 2025-03-11 | 2025-06-13 | 河南师范大学 | 一种过表达yes1基因的质粒载体及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060235255A1 (en) | 2005-04-15 | 2006-10-19 | Gartside Robert J | Double bond hydroisomerization process |
| US20090186024A1 (en) * | 2005-05-13 | 2009-07-23 | Nevins Joseph R | Gene Expression Signatures for Oncogenic Pathway Deregulation |
| RU2376372C2 (ru) * | 2007-04-03 | 2009-12-20 | Государственное учреждение Научно-исследовательский институт медицинской генетики Томского научного центра Сибирского отделения Российской академии медицинских наук | Способ генетической диагностики подверженности к сердечно-сосудистым заболеваниям |
| JP5678045B2 (ja) | 2009-06-08 | 2015-02-25 | シンギュレックス・インコーポレイテッド | 高感度バイオマーカーパネル |
| US20140040264A1 (en) * | 2011-02-04 | 2014-02-06 | Hgh Tech Campus | Method for estimation of information flow in biological networks |
| EP2549399A1 (en) | 2011-07-19 | 2013-01-23 | Koninklijke Philips Electronics N.V. | Assessment of Wnt pathway activity using probabilistic modeling of target gene expression |
| CN103959486A (zh) | 2011-12-08 | 2014-07-30 | 皇家飞利浦有限公司 | 具有厚金属层的半导体发光器件 |
| AU2013368945B2 (en) | 2012-12-26 | 2020-01-23 | Innosign B.V. | Assessment of cellular signaling pathway activity using linear combination(s) of target gene expressions |
| WO2014174003A1 (en) | 2013-04-26 | 2014-10-30 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signalling pathway activities |
-
2014
- 2014-04-24 WO PCT/EP2014/058326 patent/WO2014174003A1/en not_active Ceased
- 2014-04-24 KR KR1020157033676A patent/KR102256141B1/ko not_active Expired - Fee Related
- 2014-04-24 JP JP2016509460A patent/JP6603208B2/ja active Active
- 2014-04-24 AU AU2014259459A patent/AU2014259459B2/en not_active Ceased
- 2014-04-24 CN CN201480023555.6A patent/CN105121665B/zh active Active
- 2014-04-24 US US14/785,400 patent/US11309059B2/en active Active
- 2014-04-24 RU RU2015150464A patent/RU2718647C2/ru active
- 2014-04-24 BR BR112015026736A patent/BR112015026736A2/pt active Search and Examination
- 2014-04-24 CA CA2909991A patent/CA2909991A1/en not_active Abandoned
- 2014-04-24 EP EP18162835.5A patent/EP3372695B1/en active Active
- 2014-04-24 MX MX2015014847A patent/MX366204B/es active IP Right Grant
- 2014-04-24 EP EP14721293.0A patent/EP2989211B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016519926A (ja) | 2016-07-11 |
| CA2909991A1 (en) | 2014-10-30 |
| EP3372695A1 (en) | 2018-09-12 |
| KR102256141B1 (ko) | 2021-05-27 |
| JP6603208B2 (ja) | 2019-11-06 |
| KR20160003124A (ko) | 2016-01-08 |
| RU2718647C2 (ru) | 2020-04-10 |
| AU2014259459A1 (en) | 2015-12-17 |
| EP2989211B1 (en) | 2018-06-13 |
| US11309059B2 (en) | 2022-04-19 |
| RU2015150464A (ru) | 2017-06-02 |
| EP2989211A1 (en) | 2016-03-02 |
| WO2014174003A1 (en) | 2014-10-30 |
| CN105121665A (zh) | 2015-12-02 |
| US20160110494A1 (en) | 2016-04-21 |
| BR112015026736A2 (pt) | 2017-07-25 |
| MX2015014847A (es) | 2016-03-11 |
| AU2014259459B2 (en) | 2020-03-26 |
| EP3372695B1 (en) | 2020-09-09 |
| CN105121665B (zh) | 2019-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015014847A (es) | Pronostico medico y prediccion de la respuesta al tratamiento utilizando multiples actividades de la trayectoria de señalizacion celular. | |
| Galama et al. | Grossman’s missing health threshold | |
| MX2016004899A (es) | Metodos para evaluar el desarrollo de bebes y niños via rastreo ocular. | |
| MX2016005159A (es) | Metodos de diagnostico y tratamiento de trastornos eosinofilicos. | |
| HK1205964A1 (en) | Kit and devices for organ perfusion | |
| WO2016094904A8 (en) | Methods of measuring erbb signaling pathway activity to diagnose and treat cancer patients | |
| EP4601278A3 (en) | System and device of dynamic glucose profile response to physiological parameters | |
| GEP20166449B (en) | Treatment of pain associated with dislocation of basal endometrium | |
| BR112014029301A2 (pt) | métodos de tratamento de síndrome metabólica através de modulação da proteína choque térmico (hsp) 90-beta | |
| BR112015022825A2 (pt) | métodos de diagnóstico, seleção e tratamento de doenças e condições causadas por ou associadas a metanógenos | |
| MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
| WO2014125378A3 (en) | Systems and methods for managing and dynamically predicting respiratory episodes | |
| WO2014159926A3 (en) | Medical treatment management | |
| WO2015067710A3 (en) | Tyrp1, a natural mirna sponge, and its use in managing human melanoma aggressiveness | |
| UA78641U (ru) | Способ прогнозирования тяжести больных острым панкреатитом | |
| MX378093B (es) | Composiciones para usarse en el tratamiento de linfoma cutáneo de células t. | |
| IL223544A (en) | System and method for determining by an external entity the human hierarchial structure of an organization. using public social networks | |
| BR112014019274A2 (pt) | métodos relacionados ao tratamento de doenças e distúrbios inflamatórios | |
| WO2014179487A3 (en) | Health care communications management system and method of use | |
| UA86357U (ru) | Способ прогнозирования эффективности лечения больных с синдромом сухого глаза на фоне поствариэктомического синдрома | |
| D’Alo | Chloramine-T Anaphylaxis: case report | |
| Shimokawaji et al. | Pre-Treatment With Clarithromycin Modulates LPS-Stimulated IL-8 Secretion In Association With Modulation Of IL-8 MRNA And ERK In Normal Human Bronchial Epithelial Cells | |
| UA83553U (ru) | Способ прогнозирования развития рецидивирующего течения пиелонефрита | |
| WO2018222432A8 (en) | A predictive biomarker for let-7 microrna-based therapeutics for the treatment of human cancer | |
| Bivens et al. | Attachment, Oxytocin, and Cortisol Reactivity in Young Women after Romantic Break-up |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |